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Physical Activity, Sedentary Time, and Cardiovascular Disease
Biomarkers at Age 60 to 64 Years
Ahmed Elhakeem, PhD; Rachel Cooper, PhD; Peter Whincup, PhD; Soren Brage, PhD; Diana Kuh, PhD; Rebecca Hardy, PhD
Background-—We examined associations of objectively measured physical activity (PA) and sedentary time with cardiovascular
disease biomarkers at age 60 to 64 years. This included investigation of sex differences and the extent to which associations may
be mediated by adiposity.
Methods and Results-—Participants were 795 men and 827 women aged 60 to 64 years from the Medical Research Council
National Survey of Health and Development. Combined heart rate and movement sensors worn for 5 consecutive days were used
to derive overall PA energy expenditure, kJ/kg per day) and time spent sedentary (<1.5 metabolic equivalent of tasks), in light PA
(1.5–3 metabolic equivalent of tasks) and moderate-to-vigorous intensity PA (>3 metabolic equivalent of tasks). Linear regression
models were used to relate each PA parameter to inﬂammatory (C-reactive protein, interleukin-6), endothelial (tissue-plasminogen
activator, E-selectin) and adipokine (leptin, adiponectin) markers extracted from fasting blood samples. Greater time in light PA and
moderate-to-vigorous intensity PA and less sedentary time were associated with more favorable biomarker levels. For C-reactive
protein, interleukin-6, and leptin, these differences were greater among women than men. For example, % differences (95%
conﬁdence intervals) in leptin for men and women per SD increases in sedentary time: 7.9 (2.7, 13.0) and 20.6 (15.3, 25.8);
moderate-to-vigorous intensity PA: 3.8 (8.9, 12.7) and 17.7 (23.1, 12.4), moderate-to-vigorous intensity PA: 12.9
(17.9, 8.0) and 18.3 (23.4, 13.1). Fat mass mediated a greater proportion of these associations in women than men.
Conclusions-—Greater light PA and moderate-to-vigorous intensity PA and less sedentary time in early old age were associated
with more favorable cardiovascular biomarker proﬁles. Fat mass partially mediated these associations but more strongly in women
than men, which explained sex differences. ( J Am Heart Assoc. 2018;7:e007459. DOI: 10.1161/JAHA.117.007459.)
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P hysical inactivity is a well-known risk factor for cardio-vascular disease (CVD)1,2 and premature mortality from
CVD.2–4 One explanation for these ﬁndings is thought to be
because of beneﬁcial effects of physical activity (PA) on
endothelial function and the relatively less well-studied
biomarkers of atherosclerosis.5–12 The anti-inﬂammatory
effects of PA have been well documented with consistent
ﬁndings of decreases in pro-inﬂammatory markers C-reactive
protein (CRP) and interleukin-6 (IL-6) following brief exercise
interventions,8,9 in addition to decreases in leptin and
increases in adiponectin levels with exercise-induced fat
loss.5 PA also improves endothelial function in terms of its
ability to release the protein tissue-plasminogen activator
(t-PA), but the inﬂuence of PA on the cell adhesion molecule E-
selectin is uncertain.6 A better understanding of how PA
relates to these markers may provide insight into underlying
pathways leading to the development of atherosclerosis.13
Few epidemiological studies have examined relations
between PA intensity and these CVD biomarkers, with the
majority focusing on moderate-to-vigorous-intensity PA
(MVPA). Light-intensity PA (LPA) makes up a growing propor-
tion of the amount of time spent in PA at older age,14,15
meaning it is also important to identify whether LPA in later
life provides cardiovascular beneﬁt or whether higher PA
intensities are needed. This is challenged by reliance on poor
estimates of PA intensity (especially lower-intensity PA)
obtained from self-reported data; thus, studies where PA is
objectively assessed are needed. Furthermore, sedentary
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behavior, where energy expenditure is minimal and prolonged
lying or sitting is the dominant posture, has also been related
to an increased CVD risk independently of PA,16,17 though
little is known on how time spent sedentary relates to CVD
biomarkers at older age.
Importantly, whether associations between PA parameters
and these CVD biomarkers vary between men and women is
unknown, since the few existing studies either only included
men18 or did not report tests for sex differences,19,20 despite
hypothesized sex differences in these associations.21 More-
over, higher adiposity, which is an establishedCVD risk factor,22
has also been related to an adverse biomarker proﬁle,23
and might help explain associations between PA and CVD
biomarkers24; however, to what extent adiposity mediates
these associations is unclear, especially as PA and adiposity
associations are still widely debated.25,26 Additionally, among
older adults, women tend to have a higher fat mass for a given
body mass index than men,27 meaning it is important to study
the mediating role of more direct measures of adiposity.
Targeting adiposity could be included within all-inclusive PA
interventions and likewise, a better understanding of underlying
sex-differences would also inform intervention design.
Therefore, the aim of this study was to examine how
overall PA volume, time spent sedentary and at lower and
higher PA intensities relate to CVD biomarkers in early old
age. Speciﬁcally, we address important gaps in the existing
literature by testing whether ﬁndings differed by sex, whether
LPA and sedentary time were related to biomarkers indepen-
dently of MVPA, and the extent to which adiposity mediates
associations and explains sex-differences. We hypothesized
that greater time spent in MVPA and LPA and less sedentary
time would be associated with more favorable levels of CVD
biomarkers, and that fat mass would partly mediate these
associations.
Methods
Study Population
Data used in this publication are available to bona ﬁde
researchers upon request to the MRC National Survey of
Health and Development (NSHD) Data Sharing Committee via
a standard application procedure. Further details can be found
on the study website and data set doi’s (https://www.nshd.
mrc.ac.uk/).28 The MRC NSHD is a socially stratiﬁed British
cohort of 5362 males and females followed up at regular
intervals since birth during 1 week in March 1946.29,30
Between 2006 and 2010 (at age 60–64), a total of 2856
eligible study members (those still alive and with a known
address in England, Scotland, or Wales) were invited for an
assessment at 1 of 6 clinical research facilities, or to be
visited by a research nurse at home. Invitations were not sent
to those who had died (n=778), were living abroad (n=570),
had previously withdrawn from the study (n=594), or been lost
to follow-up (n=564). Of those invited, 2229 (78%) were
assessed: 1690 attended a clinical research facility and the
remaining 539 were seen at home.31
Ethical approval for the study at age 60 to 64 years was
obtained from the Greater Manchester Local Research Ethics
Committee and the Scotland A Research Ethics Committee.
Written, informed consent was obtained from study members
for each component of the data collection.
Cardiovascular Disease Biomarkers
Overnight fasting blood samples were taken during the clinical
assessment and initially processed at the clinical research
laboratories. Aliquots were frozen and stored before being
transferred to the MRC Human Nutrition Research laboratory in
Cambridge where analyses of inﬂammatory marker CRP was
processed according to standardized protocols. Analyses of
adipokines (leptin and adiponectin), endothelial markers (E-
selectin and t-PA), and inﬂammatory marker IL-6 were
undertaken by British Heart Foundation Research Centre in
Glasgow. The method and commercial assay plus interassay
coefﬁcients of variation are given in Table S1.
Clinical Perspective
What Is New?
• We examined how time spent sedentary and in different
activity intensities (as well as cardiorespiratory ﬁtness)
relates to inﬂammatory, endothelial, and adipokine markers
in 60- to 64-year-old men and women.
• Less sedentary time and greater time in low and moderate-
to-vigorous intensity activity were associated with favorable
biomarker proﬁles.
• Fat mass partly explained associations and to a greater
extent in women.
• Differences in interleukin-6, tissue plasminogen activator,
and leptin by sedentary time and light activity were
independent of higher intensity activity.
• Cardiorespiratory ﬁtness was associated with biomarkers,
but this was largely mediated by fat mass.
• Physical activity volume was related to biomarkers inde-
pendently of ﬁtness.
What Are the Clinical Implications?
• Sedentary and inactive older adults should be supported to
replace time spent sedentary with any intensity of physical
activity.
• Activities that can reduce fat mass may be most beneﬁcial
for cardiovascular health.
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PA and Sedentary Time
At the end of their clinical assessment at age 60 to 64 years,
study participants were invited to wear a combined movement
(from acceleration) and heart rate monitor (Actiheart,
CamNtech, Ltd, Papworth, United Kingdom) attached to their
chest for 5 consecutive days.32 Heart rate and movement
data were recorded in 30-s epochs to derive measures of free-
living PA. Heart rate data were preprocessed33 and then
individually calibrated using an 8-minute step test to account
for between-individual differences in the relationship between
PA intensity and heart rate34; group calibration was used
where individual calibration was not carried out, adjusted only
for sleeping heart rate, age, sex, and b-blocker use.34 Total PA
energy expenditure (PAEE) (in kJ/kg per day) was derived
using a branched equation framework35 as recently validated
in a UK population36 from which time spent at different PA
intensities was summarized; these were based on metabolic
equivalent of tasks (METs) as time spent sedentary (<1.5
METs) and in LPA (1.5–3 METs) and MVPA (>3 METs), using 1
standard MET (20.35 J/ mL O293.5 mL O2/ min per kg) as
resting metabolic rate.
This standard deﬁnition of 1 MET, which summarized
intensity regardless of body composition, was used so as to
avoid overestimation of PA intensity with higher body mass
index. PA parameters were adjusted for wear time and diurnal
information bias to allow for variation between individuals in
wear time at different times of the day when levels of PA may
be expected to vary. Following visual inspection of heart rate
and movement traces, participants were excluded if acceler-
ation signals were corrupted or where valid heart rate
measurements were not available (n=55). Those with
<48 hours of wear time (n=24) were excluded to ensure PA
data were an accurate reﬂection of normal PA. All PA
parameters were sex-standardized to mean=0 and SD=1. In
addition, in the subsample with sufﬁcient step test data
(≥4 minutes), we derived cardiorespiratory ﬁtness by extrap-
olating the submaximal relationship between heart rate and
energy expenditure to age-predicted maximal heart rate; the
latter was adjusted downwards by 20 beats per minute for
individuals on b-blockers to reﬂect their lower maximal heart
rate.37 The estimate was expressed as maximal oxygen
uptake (VO2max; mL O2/min per kg).
Covariates
Socioeconomic position, smoking history, long-term illness,
health problem or disability, blood pressure, diabetes mellitus,
CVD, and medication use were selected a priori for inclusion
in analyses. Educational level and occupational class were
used as indicators of socioeconomic position. Education was
based on highest level attained by age 26 and categorized as
none; vocational/O-levels or their equivalents; A-levels or
their equivalents; and degree or higher. Occupational class
was based on the Registrar General’s social classiﬁcation at
age 53 (or at younger ages if missing) and categorized as
professional and intermediate (I&II); skilled nonmanual (IIINM);
skilled manual (IIIM); and semiskilled and unskilled manual
(IV&V). Smoking history up to age 60 to 64 years was grouped
as never, former, or current. At age 60 to 64 years,
participants reported whether they had any long-term illness,
health problems or disability that limits their activity, and self-
reported doctor diagnoses of diabetes mellitus, stroke,
angina, and myocardial infarction. Also, at age 60 to 64
years, blood pressure was assessed by nurses using an
Omron device, and participants reported their use of antihy-
pertensive medication, b-blockers, nitrates, and lipid-lowering
drugs. Age at measurement was recorded.
We hypothesized that body size and speciﬁcally adiposity
may mediate associations between PA parameters and CVD
biomarkers. As a result, fat mass index (whole body fat mass
excluding head (kg)/height (m)1.2, standardized to mean=0
and SD=1) obtained from QDR 4500 Discovery dual-energy
X-ray absorptiometry scanner (Hologic Inc, Bedford, MA)
among the subsample of participants who attended a clinical
research facility at age 60 to 64 years was included in
analyses.
Statistical Analysis
All biomarkers (CRP, IL-6, E-selectin, t-PA, leptin, and
adiponectin) were positively skewed and therefore trans-
formed using the natural logarithm. All analyses were carried
out separately in men and women (with formal tests of sex
interactions in associations of each PA parameter and each
biomarker tested in models with men and women combined).
Evidence of nonlinearity was examined by adding a quadratic
term for each PA parameter measure, with quadratic models
retained if evidence of nonlinearity was found.
Initial models were adjusted for age and subsequent
models were further adjusted for covariates (socioeconomic
position, smoking history, long-term illness, health problem or
disability, blood pressure, medication use, and CVD). To
examine the inﬂuence of adiposity on any sex differences
found, we ﬁtted third models with additional adjustment for
fat mass index (sex-stratiﬁed models and sex-combined
models with interaction terms for PA parameter-by-sex). We
also used these third models to explore mediation via
adiposity, by comparing the degree of attenuation in
estimates before and after adjustment for fat mass index.
To examine whether sedentary time and LPA were associated
with biomarkers independently of MVPA, we ﬁtted additional
models with mutual adjustment for (1) sedentary time and
MVPA, and (2) LPA and MVPA, similar to a recent study
examining independence of these associations in older
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men.18 This approach was chosen since a high degree of
multicollinearity precluded simultaneous adjustment for all 3
PA measures.
To minimize the potential for bias because of missing
data in these regression analyses, we used multiple
imputation by chained equations38 to impute missing data
for all covariates in participants with complete data on PA
parameters and at least 1 biomarker (n=up to 387 men and
312 women in total; education: n=86, occupational class:
n=8, smoking history: n=136, long-term illness, health
problem, or disability: n=4, blood pressure: n=7, diabetes
mellitus: n=132, angina and/or myocardial infarction:
n=175, stroke: n=133, medication use: n=0, and fat mass
index: n=398). Imputation models were ﬁtted separately for
each biomarker and run using 20 multiply imputed data sets
that were combined using Rubin’s combination rules.
Findings from multiple imputation and complete-case anal-
yses were similar so the former are presented. All results
were presented as percentage difference in biomarker levels
since biomarkers are logged.39
In additional analyses, we used structural equation mod-
eling to quantify the degree of mediation (and conﬁrm
partial mediation) related to our hypothesized mediation
model by estimating direct and indirect (through fat mass)
paths between each PA parameter and each biomarker.
These models were estimated separately in men and
women after adjustment for all covariates using full
information maximum likelihood to deal with missing data.
Finally, we performed an additional analysis (after multiple
imputation of missing covariates) to examine how car-
diorespiratory ﬁtness relates to these biomarkers and the
role of fat mass in explaining these associations. We also
performed a ﬁnal model with both VO2max and PAEE to
examine whether they were independently related to
biomarkers. All analyses were carried out in STATA 14
(StataCorp, College Station, TX).
Sensitivity Analyses
To examine whether associations differed substantially in
those with clinically manifest CVD or diabetes mellitus, we
reﬁtted all models after excluding those with CVD (stroke,
angina, and myocardial infarction) and diabetes mellitus
diagnoses up to age 60 to 64 years (n=up to 201 men and
162 women). Additionally, we re-examined associations with
CRP after excluding levels indicative of acute infection
(>10 mg/L) (n=47 men and 50 women). We also repeated
analyses after excluding those on b-blockers (n=174), as this
may affect quantiﬁcation of PAEE and ﬁtness from heart rate
data. Lastly, analyses were repeated using average trunk
acceleration (m/s2) as a measure of overall PA instead of
PAEE.27
Results
Descriptive Statistics
Of the 2229 participants with a clinic or home visit at age 60
to 64 years, 2065 (92.6%) had data on ≥1 biomarker and, of
these, 1622 (51.0% female) also had data on PA and
sedentary time (Table 1). Women had higher levels of
adiponectin and leptin than men, while men had higher levels
of E-selectin and t-PA (Table 1). Men spent greater time in
MVPA than women (Table 1). Participants without CVD had
more favorable levels of biomarkers than those with CVD
(Figure 1). Those without CVD had higher median PA and
lower sedentary time than those with CVD (PAEE: 35.0 versus
30.0 kJ/kg per day; MVPA: 0.58 versus 0.40 h/d; LPA: 5.4
versus 4.7 h/d; sedentary time: 17.8 versus 18.7 h/d). Mean
VO2max was higher in men than women (31.4 versus 28.5 mL
O2/min per kg) and in those without CVD (30.1 versus
29.3 mL O2/min per kg).
PA and Inﬂammatory Markers (CRP and IL-6)
Greater sedentary time was associated with higher CRP and
IL-6 and associations were stronger in women than men and
were maintained after adjustment for covariates (Figure 2).
Accounting for fat mass largely reduced sex differences
(Figure 2); fat mass partly mediated overall associations but
to a greater extent for women (Figure 2, Table 2). Greater
time spent in LPA and MVPA was related to lower CRP and IL-
6 in both sexes, but these associations were considerably
stronger in women even after accounting for covariates
(Figure 2). Further adjustment for fat mass attenuated sex-
differences (Figure 2) and only partially mediated associa-
tions, though with greater mediation in women than men
(Figure 2, Table 2). Associations between PAEE and CRP and
IL-6 were similar to those observed for MVPA (Figure 2). The
associations of sedentary time and LPA with IL-6 (women)
were maintained after adjustment for MVPA but associations
with CRP largely attenuated (Figure 3). These adjustments
had little inﬂuence on MVPA-CRP/IL-6 associations, with
mutual adjustment for sedentary time resulting in a greater
reduction in differences when compared with mutual adjust-
ment for LPA (Figure 3).
PA and Endothelial Markers (t-PA and E-Selectin)
Higher sedentary time was related to higher t-PA in both men
and women, including after accounting for covariates and fat
mass (Figure 4). Higher LPA was related to lower t-PA in both
men and women, and this association was only slightly
attenuated by adjustment for covariates and partially medi-
ated by fat mass (Figure 4, Table 2). Greater time spent in
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Table 1. Characteristics of Participants From the Medical Research Council National Survey of Health and Development With Data
on Monitored Physical Activity and Sedentary Time and at Least 1 Biomarker at Age 60 to 64 Years
Men (n=795) Women (n=827)
P Sex
Difference
Cardiovascular disease biomarkers (geometric mean [95% CI])
Inflammatory markers
C-reactive protein (mg/L) 2.2 (2.1, 2.3) 2.4 (2.2, 2.5) 0.700
IL-6 (pg/mL) 2.1 (2.0, 2.2) 2.0 (1.9, 2.1) 0.108
Endothelial markers
Tissue-plasminogen activator (ng/mL) 8.9 (8.5, 9.3) 8.0 (7.7, 8.4) <0.001
E-selectin (ng/mL) 36.2 (35.1, 37.4) 34.1 (33.1, 35.2) 0.004
Adipokines
Leptin (ng/mL) 7.3 (6.9, 7.7) 20.0 (19.0, 21.2) <0.001
Adiponectin (lg/mL) 8.8 (8.3, 9.2) 15.9 (15.3, 16.6) <0.001
Physical activity variables (median [25th, 75th percentiles])
PAEE (kJ/kg per day) 35.7 (26.9, 47.5) 33.5 (25.2, 41.8) <0.001
Sedentary time (<1.5 METs) (h/d) 17.9 (16.2, 19.4) 18.0 (16.6, 19.4) 0.317
Light-intensity activity (1.5–3 METs) (h/d) 5.2 (4.0, 6.5) 5.4 (4.3, 6.7) 0.042
MVPA (>3 METs) (h/d) 0.7 (0.3, 1.2) 0.4 (0.2, 0.8) <0.001
Covariates
Educational level (N [(%)])
None 238 (31.5) 237 (30.0) <0.001
Vocational/O-level GCSEs 153 (20.3) 285 (36.1)
A-level GCSEs 236 (31.3) 220 (27.9)
Degree or equivalent 128 (17.0) 47 (6.0)
Occupational class (N [%])
I&II 444 (55.9) 331 (40.0) <0.001
IIINM 85 (10.7) 289 (35.0)
IIIM 192 (24.2) 65 (7.9)
IV&V 74 (9.3) 142 (17.2)
Smoking history (N [%])
Current smoker 71 (9.8) 89 (11.6) 0.013
Ex-smoker 440 (60.4) 405 (52.9)
Never smoked 217 (29.8) 272 (35.5)
Long-term illness, health problem, or disability (N [%])
No 624 (78.3) 619 (74.7) 0.085
Yes 173 (21.7) 210 (25.3)
Ever diagnosed with diabetes mellitus (N [%])
No 672 (92.6) 730 (94.6) 0.115
Yes 54 (7.4) 42 (5.4)
Ever diagnosed with angina or MI (N [%])
No 650 (91.4) 718 (96.6) <0.001
Yes 61 (8.6) 25 (3.4)
Ever diagnosed with stroke (N [%])
Continued
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MVPA was related to lower t-PA in both sexes, but these
associations were considerably stronger in women, even after
accounting for covariates (Figure 4). Fat mass partially
mediated these associations (Figure 4, Table 2). In both
men and women, higher PAEE was associated with lower t-PA
both before and after adjustment for covariates and fat mass
(Figure 4). Greater time in MVPA was weakly associated with
lower E-selectin but association was attenuated by adjust-
ment for covariates whereas sedentary time, LPA, and PAEE
were not associated with E-selectin (Figure 4). Associations of
sedentary time and LPA with t-PA (men) persisted after
adjustment for MVPA (Figure 3).
PA and Adipokines (Leptin and Adiponectin)
Greater sedentary time was associated with higher leptin and
lower adiponectin including after adjustment for covariates,
and differences were larger in women (Figure 5). Controlling
for fat mass reduced these sex differences, but fat mass only
partially mediated associations (Figure 5, Table 2). Greater
LPA was associated with lower leptin and higher adiponectin
in women but not men; associations persisted after adjust-
ments and were partially mediated by fat mass (Figure 5,
Table 2). MVPA was related to lower leptin and higher
adiponectin in both sexes, but associations with leptin were
stronger in women (Figure 5). Associations between MVPA
and leptin were maintained, but those with adiponectin
reduced after accounting for covariates (Figure 5). Adjust-
ment for fat mass attenuated sex-differences and partially
mediated these associations (Figure 5, Table 2). Associations
Table 1. Continued
Men (n=795) Women (n=827)
P Sex
Difference
No 712 (97.9) 759 (98.6) 0.347
Yes 15 (2.1) 11 (1.4)
Use of b-blockers (N [%])
No 706 (88.4) 749 (90.1) 0.248
Yes 93 (11.6) 82 (9.9)
Use of antihypertensive and/or heart failure drugs (N [%])
No 611 (76.5) 686 (82.6) 0.002
Yes 188 (23.5) 145 (17.5)
Use of nitrates (N [%])
No 680 (85.1) 750 (90.3) 0.002
Yes 119 (14.9) 81 (9.8)
Use of lipid-lowering drugs (N [%])
No 564 (70.6) 673 (81.0) <0.001
Yes 235 (29.4) 158 (19.0)
Diastolic blood pressure (mm Hg) (arithmetic mean (95% [CI]) 79.4 (78.7, 80.1) 75.8 (75.2, 76.5) <0.001
Fat mass index (kg/m1.2) (arithmetic mean [95% CI]) 7.7 (7.5, 7.8) 11.0 (10.8, 11.3) <0.001
Mean (SD) in physical activity (PA) parameters formen andwomen, respectively: PA energy expenditure=38.3 (15.8) and 34.5 (13.4) kJ/kg per day,moderate-to-vigorous-intensity PA=0.9 (0.8)
and 0.6 (0.6) h/d, light-intensity PA=5.4 (1.8) and 17.9 (2.1) h/d, sedentary time=17.7 (2.2) and 17.9 (2.1) h/d. CI indicates conﬁdence interval; GCSEs, General Certiﬁcate of Secondary
Education; IL-6, interleukin-6; METs, metabolic equivalents of task; MI, myocardial infarction; MVPA, moderate-to-vigorous physical activity; PAEE, physical activity energy expenditure.
Figure 1. Mean biomarkers in those without and with cardio-
vascular disease (CVD) diagnoses. Median biomarker values in
those without and with CVD diagnoses, respectively, were: CRP=2
and 2.5 mg/L, IL-6=1.8 and 2.4 (pg/mL), t-PA=9.0 and 10.2 (ng/
mL), E-selectin=36.5 and 39.1 (ng/mL), leptin=11.8 and 13.9
(ng/mL), and adiponectin=12.8 and 8.3 (lg/mL). CVD diagnoses
include diabetes mellitus, stroke, angina, and myocardial infarc-
tion. *P≤0.05, **P≤0.01, ***P≤0.001. CRP indicates C-reactive
protein; IL-6, interleukin-6; t-PA, tissue plasminogen activator.
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of PAEE with leptin and adiponectin were similar to those
observed for LPA (Figure 5). Sedentary time and LPA
remained associated with leptin and adiponectin (women)
after adjustment for MVPA (Figure 3). These adjustments had
little inﬂuence on MVPA-leptin/adiponectin associations, with
mutual adjustment for sedentary time resulting in a greater
reduction in differences when compared with adjustment for
LPA (Figure 3).
Cardiorespiratory Fitness and CVD Biomarkers
There was no evidence of sex-interactions in the associations
of VO2max estimates with CVD biomarkers (P>0.1 for all tests
of interactions); therefore, results are presented for men and
women combined (n=1035–1062). Higher VO2max was
associated with better levels of all biomarkers except for
the adipokine marker adiponectin, which showed no
Figure 2. Mean percentage difference (95% conﬁdence intervals) in inﬂammatory markers (CRP and IL-6)
per SD increases in time spent sedentary (SED), in light- (LPA) and moderate-to-vigorous-intensity physical
activity (MVPA), and overall physical activity energy expenditure (PAEE) at age 60 to 64 years. Model 1
adjusted for age. Model 2 adjusted for age, SEP, smoking history, long-term illness, health problem or
disability, blood pressure, CVD, and medication use. Model 3 as for model 2 plus adjustment for fat mass
index. P for sex interaction from sex-combined models. Sex interaction tests based on nonstandardized PA
measures. *P≤0.05, **P≤0.01, ***P≤0.001. CI indicates conﬁdence interval; CRP, C-reactive protein; IL-6,
interleukin-6.
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signiﬁcant association; in contrast, the largest difference by
VO2max was found for leptin (Figure 6). Adjustment for
covariates had little inﬂuence on the associations found;
however, in all cases, associations were largely mediated by
fat mass (Figure 6). This was conﬁrmed by path analysis,
which showed that the proportion of associations mediated by
fat mass were 89.7% for CRP, 85.5% for IL-6, 80.0% for t-PA,
68.3% for E-selectin, and 82.4% for leptin. When VO2max and
overall PA volume were included in the same model (after
adjustment for all covariates and fat mass), SD differences in
PAEE were inversely associated with CRP (6.1%; 11.8 to
0.5), IL-6 (8.7%; 13.3 to 4.2), and leptin (5.3%; 8.8
to 1.7), whereas VO2max was inversely associated with t-PA
(3.6%; 7.8 to 0.7) and E-selectin (3.1%; 6.3 to 0.1).
Sensitivity Analyses
Associations between PA parameters and biomarkers were
similar after excluding participants with CVD and diabetes
mellitus (Table S2). Associations with CRP were similar after
excluding participants with levels >10 mg/L; for example, %
changes in CRP per SD increase in time spent at MVPA was
2.0% (6.8, 2.8) in men and 5.1% (9.8, 0.6) in women
(adjusted for covariates and fat mass index). Our ﬁndings
were also similar after excluding participants on b-blockers.
When average trunk acceleration was used instead of PAEE,
associations with E-selectin and leptin were similar but
associations with CRP, IL-6 (men), t-PA (women), and
adiponectin (women) were weaker (not shown).
Discussion
Main Findings
We examined associations of time spent sedentary, in low-
and moderate-to-vigorous-intensity activity, and overall phys-
ical activity energy expenditure from individually calibrated
combined heart rate and movement sensors with inﬂamma-
tory, endothelial, and adipokine markers in 60- to 64-year-old
men and women from a nationally representative British birth
cohort. Except for E-selectin, which largely showed no
associations, less sedentary time and greater time spent in
LPA and MVPA and higher PAEE were all associated with more
favorable CVD biomarker proﬁles even after adjustment for a
wide range of covariates. For CRP, IL-6, leptin, and less so for
adiponectin, associations were stronger among women than
men (on both relative and absolute scales), but sex differ-
ences were largely explained by the greater fat mass of
women for a given body mass index. Adiposity only partly
mediated associations, and in general this mediation was
greater in women than men. Except for t-PA and leptin,
differences in biomarker levels were greater for MVPA than
sedentary time and LPA. Sedentary time and LPA were
associated with IL-6, t-PA, and leptin independently of MVPA.
In addition, we also found associations between higher
cardiorespiratory ﬁtness and favorable biomarker levels,
which were largely mediated by adiposity.
Comparison With Other Studies
This is one of the ﬁrst studies to comprehensively investi-
gate the associations of PA and sedentary time with a wide
range of CVD biomarkers at older age in both men and
women. Our ﬁndings are consistent with the few other
studies that have investigated associations between some of
these PA parameters and some of these CVD biomarkers.
These include results from men aged in their 70s from the
British Regional Heart Study showing that higher MVPA was
associated with lower levels of IL-6, CRP, and t-PA, and that
associations between sedentary time and IL-6 or t-PA were
independent of MVPA.18 Our results also agree with ﬁndings
Table 2. Percentage of the Association Between Each
Physical Activity Parameter and Each Biomarker That Is
Mediated by Fat Mass Index in Men and Women: Path
Analysis
PAEE MVPA LPA SED
CRP
Men 38.8 38.3 37.1 39.2
Women 50.6 49.8 57.7 54.5
IL-6
Men 22.7 20.9 35.0 26.7
Women 40.6 39.7 46.5 43.4
t-PA
Men 26.0 67.4 8.4 16.0
Women 52.3 49.3 57.7 54.3
E-selectin
Men 55.9 84.5 18.5 40.7
Women 76.0 77.8 84.1 82.1
Leptin
Men 59.4 58.0 64.9 61.3
Women 67.7 63.3 71.7 69.1
Adiponectin
Men 52.0 64.5 21.4 34.4
Women 54.3 92.7 38.6 43.8
Data show % of the total effects of each activity parameter that is mediated by fat mass
index (indirect effect through fat mass/total effect). Adjusted for age, SEP, smoking
history, long-term illness, health problem or disability, blood pressure, cardiovascular
disease, and medication use. CRP indicates C-reactive protein; IL-6, interleukin-6; LPA,
light-intensity physical activity; MVPA, moderate-to-vigorous physical activity; PAEE,
physical activity energy expenditure; SED, sedentary; SEP, socioeconomic position; t-PA,
tissue-plasminogen activator.
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Figure 3. Mean percentage difference (95% conﬁdence intervals) in biomarkers after mutual adjustment of sedentary time (SED) and light-
intensity physical activity (LPA) for moderate-to-vigorous-intensity physical activity (MVPA). Models adjusted for covariates (age, SEP, smoking
history, long-term illness, health problem or disability, blood pressure, CVD, medication use, and fat mass index) plus MVPA (separately for LPA
and SED). Estimates represent 1 SD increases in each PA parameter. *P≤0.05, **P≤0.01, ***P≤0.001. CRP indicates C-reactive protein; CVD,
cardiovascular disease; IL-6, interleukin-6; SEP, socioeconomic position; t-PA, tissue plasminogen activator.
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from National Health and Nutrition Examination Survey
showing that LPA and MVPA were related to better
cardiometabolic biomarkers and that associations with
triglycerides and blood pressure were stronger in women.40
Likewise, our results support other ﬁndings from National
Health and Nutrition Examination Survey showing indepen-
dent associations between higher sedentary time and more
adverse levels of cardiometabolic biomarkers,41 and ﬁndings
in older women of associations between both LPA and MVPA
and lower CRP.42 Our ﬁndings are important as they show
that greater time spent in LPA in early old age, which makes
up much of the time spent in PA by older adults,43 is
associated with a better CVD biomarker proﬁle. It also
highlights marked sex differences, with associations being
stronger in women and driven largely by sex differences in
body composition.
Figure 4. Mean percentage difference (95% conﬁdence intervals) in endothelial markers (t-PA and E-
selectin) per SD increases in time spent sedentary (SED), in light- (LPA) and moderate-to-vigorous intensity
physical activity (MVPA), and overall physical activity energy expenditure (PAEE) at age 60 to 64 years.
Model 1 adjusted for age. Model 2 adjusted for age, SEP smoking history, long-term illness, health problem
or disability, blood pressure, CVD, and medication use. Model 3 as for model 2 plus adjustment for fat mass
index. P for sex interaction from sex-combined models. Sex interaction tests based on nonstandardized PA
measures. *P≤0.05, **P≤0.01, ***P≤0.001. CI indicates conﬁdence interval; CVD, cardiovascular disease;
SEP, socioeconomic position; t-PA, tissue plasminogen activator.
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Explanation of Findings
Our ﬁndings suggest that 1 way through which PA may lower
CVD risk is by improving physiological and biochemical
functions of blood vessels, as indicated by associations of LPA
and MVPA with inﬂammatory markers, adipokines, and t-PA.
The ﬁndings also suggest that increased sedentary time may
be adversely related to endothelial function as indicated by its
relation to these same markers, including to IL-6, t-PA, and
leptin independently of MVPA. Their association with these
biomarkers might mediate effects of PA and sedentary time
on structural cardiovascular remodeling,44,45 and these
effects might be more apparent in those with vascular
disease.46
That stronger associations were observed for women than
men suggests that sex differences in response to PA and
sedentary time may exist.21 For instance, it is thought that the
modulation of the cardiovascular system by PA in older adults
Figure 5. Mean percentage difference (95% conﬁdence intervals) in adipokines (leptin and adiponectin) per
SD increases in time spent sedentary (SED), in light- (LPA) and moderate-to-vigorous-intensity physical
activity (MVPA), and overall physical activity energy expenditure (PAEE) at age 60 to 64 years. Model 1
adjusted for age. Model 2 adjusted for age, SEP, smoking history, long-term illness, health problem or
disability, blood pressure, CVD, and medication use. Model 3 as for model 2 plus adjustment for fat mass
index. P for sex interaction from sex-combined models. Sex interaction tests based on nonstandardized PA
measures. *P≤0.05, **P≤0.01, ***P≤0.001. CI indicates conﬁdence interval; CVD, cardiovascular disease;
SEP, socioeconomic position.
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is in part affected by endogenous levels of sex hormones.21
Sex differences in a host of cardiovascular factors could
contribute to the heterogeneous effects of PA on these CVD
biomarkers.21 For example, these differences may be partially
explained by differences in body composition responses to
PA. This is supported by the fact that associations were not
signiﬁcantly different between men and women once differ-
ences in body composition were accounted for. This is further
supported by ﬁndings from NSHD that MVPA in early old age
was more strongly related to fat mass in women than men27
and by evidence of sex-speciﬁc associations between testos-
terone and fat mass at age 60 to 64 years.47 Further, sex-
differences were generally less marked for MVPA than lower
intensities, which suggests that higher PA intensities may be
more important in men.48
Given that associations were only partly mediated by fat
mass (albeit with greater mediation in women than men),
adiposity may not be the only route through which PA beneﬁts
cardiovascular health,49 and this is consistent with studies
showing persisting associations after adjustment for body
size.50,51 Further, our ﬁnding that fat mass mediated a large
proportion of the associations between VO2max and CVD
biomarkers is consistent with studies reporting that effects of
cardiorespiratory ﬁtness on cardiovascular structure52 and
components of the metabolic syndrome53 were explained by
adiposity. Finally, that PA was related to biomarkers after
accounting for VO2max suggests that effects of PA on CVD
may be at least partly independent of underlying ﬁtness
levels.54
Methodological Considerations
An important strength of this study is the assessment of PA
and sedentary time from combined heart rate and movement
sensors to provide more precise estimates of activity intensity
when compared with self-reports. Other important strengths
include the formal investigation of sex differences in these
associations, investigating the mediating role of adiposity, an
examination of how PA parameters relate a range of novel
biomarkers each with differing underlying roles in CVD
pathogenesis, and adjustment for important covariates. An
important limitation of this study is that it was cross-sectional,
meaning we are unable to establish temporality. Reverse
causation is possible and could partially explain our ﬁndings;
this is particularly relevant for the observed PA and ﬁtness
differences between people with and without prevalent CVD.
However, our main ﬁndings of association were broadly
similar after exclusions in sensitivity analyses of prevalent
disease, suggesting that associations did not differ substan-
tially in those further along the disease trajectory. Addition-
ally, our estimates of sedentary time included sleep and thus
do not distinguish between sedentary time because of
sleeping and sedentary time during waking hours. The weaker
associations with CRP, IL-6, t-PA, and adiponectin when using
only the (uniaxial) trunk acceleration may be because of PAEE
obtained from combined heart rate and acceleration being
better suited to capturing activities that affect these biomark-
ers. Also, participants who completed at least 4 minutes of
the step test and therefore had an estimated VO2max were
healthier than the larger sample with PA measurements and
thus ﬁndings for VO2max may be less generalizable. Finally,
doctor diagnoses were self-reported and so could be prone to
bias; however, self-reported diabetes mellitus was validated
against medical records in NSHD55 and self-reported angina
was found to correlate well with medical records in a similar-
aged sample of British men.56
Implications and Conclusions
This study showed that in early old age, an important time of
transition between work and retirement when behavior
change may be possible,57 higher PAEE and greater time
spent in LPA and MVPA and less sedentary time were related
Figure 6. Mean percentage difference (95% conﬁdence inter-
vals) in biomarkers per SD increases in cardiorespiratory ﬁtness
(VO2max) at age 60 to 64 years. Model 1 adjusted for age and
sex. Model 2 adjusted for age, sex, SEP, smoking history, long-
term illness, health problem or disability, blood pressure, CVD,
and medication use. Model 3 as for model 2 plus adjustment for
fat mass index. *P≤0.05, ***P≤0.001. CI indicates conﬁdence
interval; CRP, C-reactive protein; CVD, cardiovascular disease; IL-
6, interleukin-6; SEP, socioeconomic position; t-PA, tissue plas-
minogen activator.
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to more favorable CVD biomarker proﬁles. The associations
found were stronger in women than men and remained after
adjustment for covariates. Fat mass only partially mediated
the main associations, although it was an important mediator,
particularly in women. That is, the greater fat mass of women
for a given body mass index explained why associations were
stronger among women than men. Further, as sedentary time
and LPA were both related to inﬂammatory and endothelial
markers and adipokines independently of MVPA, our ﬁndings
suggest that it is important for sedentary and inactive older
adults to be supported to replace time spent sedentary with
any intensity of PA.
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Table S1. Methods and interassay coefficients (CV) of variation for biomarkers assessed 
from blood samples at age 60-64 years. 
 *Any results that fell below the lower detection limit of the assay were assigned a notional 
value, obtained by dividing the lower detection limit by the square root of 2.  
 
 
Cardiovascular disease 
biomarker 
Units Assay/Method CV (%) 
    
E-selectin ng/ml High sensitivity ELISA <10.0% 
C-reactive protein 
(CRP) 
mg/l 
Particle-enhanced 
immunoturbidimetric assay 
4.3% at 3.4 mg/L 
1.8% at 11.9 mg/L 
Interleukin-6 (IL6) pg/ml 
Enzyme-linked immunosorbent assay 
(ELISA) 
6.5% 
Tissue plasminogen 
activator (tPA) 
ng/ml ELISA 6.6% 
Leptin ng/ml 
In-house radioimmunoassay validated 
against commercially available assays 
<10.0% 
Adiponectin μg/ml ELISA <7.5% 
 
 
Table S2. Mean percentage difference (95% confidence intervals) in biomarkers per standard deviation increases in time spent 
sedentary (SED), in light (LPA) and moderate-to-vigorous intensity physical activity (MVPA), and overall physical activity energy 
expenditure (PAEE) at age 60-64: after exclusion of participants with doctor-diagnosed cardiovascular disease. 
 Men   Women 
 Model 1  Model 2  Model 3  Model 1  Model 2  Model 3 
            
CRP (♂=684; ♀=756)         
SED 7.2 (0.5, 13.9)  4.7 (-1.9, 11.3)  5.4 (-1.2, 12.0)  17.2 (11.0, 23.4)  15.6 (9.2, 22.0)  8.8 (24.2, 15.1) 
LPA -4.8 (-11.6, 1.9)  -4.6 (-11.3, 2.1)  -4.0 (-10.5, 2.6)  -14.2 (-20.5, -8.0)  -13.1 (-19.5, -6.6)  -6.8 (-13.1, -0.5) 
MVPA -8.7 (-15.2, -2.2)  -6.1 (-12.6, 0.4)  -3.8 (-10.3, 2.7)  -17.9 (-23.9, -11.8)  -14.7 (-20.8, -8.5)  -9.2 (-15.2, -3.2) 
PAEE -9.6 (-16.2, -3.1)  -7.7 (-14.3, -1.1)  -5.5 (-12.1, 1.1)  -19.9 (-26.1, -13.7)  -17.5 (-23.9, -11.1)  -10.5 (-16.9, -4.1) 
IL-6 (♂=678; ♀=751)         
SED 7.7 (2.4, 13.1)  6.0 (0.7, 11.4)  5.0 (-0.03, 10.3)  16.3 (11.2, 21.4)  14.3 (9.0, 19.5)  10.1 (4.8, 15.4) 
LPA -4.4 (-9.7, 1.0)  -3.5 (-8.9, 1.8)  -3.1 (-8.3, 2.2)  -13.7 (-18.8, -8.9)  -12.1 (-17.3, -6.8)  -8.2 (-13.5, -2.9) 
 
 
MVPA -11.0 (-16.1, -5.9)  -8.2 (-13.3, -3.1)  -6.6 (-11.7, -1.5)  -16.2 (-21.1, -11.3)  -13.1 (-18.1, -8.1)  -9.6 (-14.6, -4.6) 
PAEE -11.1 (-16.3, -6.0)  -8.9 (-14.1, -3.6)  -7.3 (-12.5, -2.1)  -18.1 (-23.2, -13.1)  -15.6 (-20.8, -10.3)  -11.3 (-16.6, -5.9) 
t-PA (♂=623; ♀=681)         
SED 11.2 (6.2, 16.1)  9.9 (4.8, 15.0)  8.5 (3.6, 13.5)  11.7 (7.0, 16.5)  10.8 (5.7, 15.8)  6.2 (1.2, 11.3) 
LPA -10.9 (-15.8, -5.9)  -10.1 (15.1, -5.0)  -9.2 (-14.1, -4.4)  -10.2 (-15.0, -5.4)  -9.0 (-14.0, -3.9)  -5.0 (-10.0, -0.04) 
MVPA -6.1 (-10.9, -1.3)  -4.1 (-9.0, 0.8)  -2.1 (-6.9, 2.7)  -10.3 (-14.9, -5.8)  -9.9 (-14.7, -5.2)  -5.9 (-10.6, -1.2) 
PAEE -10.3 (-15.1, -5.4)  -8.6 (-13.6, -3.6)  -6.6 (-11.5, -1.6)  -12.1 (-16.8, -7.4)  -11.5 (-16.5, -6.5)  -6.7 (-11.7, -1.6) 
E-selectin (♂=678; ♀=752)         
SED 1.7 (-1.6, 5.0)  0.9 (-2.4, 4.2)  0.2 (-3.1, 3.5)  2.4 (-0.8,5.6)  2.5 (-0.9, 5.9)  0.5 (-3.0, 4.0) 
LPA -1.3 (-4.6, 2.0)  -1.0 (-4.3, 2.3)  -0.6 (-3.9, 2.6)  -1.8 (-5.1, 1.4)  -1.8 (-5.2, 1.6)  -0.09 (-3.5, 3.4) 
MVPA -1.8 (-5., 1.4)  -0.2 (-3.5, 3.0)  0.9 (-2.3, 4.1)  -3.0 (-6.1, 0.2)  -3.0 (-6.2, 0.2)  -1.5 (-4.8, 1.8) 
PAEE -2.2 (-5.4, 1.0)  -0.8 (-4.1, 2.5)  0.3 (-2.9, 3.6)  -2.8 (-6.0, 0.4)  -2.9 (-6.3, 0.5)  -0.9 *-4.4, 2.6) 
Leptin (♂=680; ♀=753)         
SED 10.8 (5.2, 16.3)  7.6 (2.1, 13.0)  3.4 (-0.7, 7.6)  23.2 (17.8, 28.7))  18.8 (13.2, 24.3)  5.3 (1.0, 9.6) 
LPA -5.8 (-11.4, -0.2)  -3.3 (-8.7, 2.1)  -1.2 (-5.3, 2.9)  -19.8 (-25.3, -14.3)  -15.7 (-21.3, -10.1)  -3.7 (-7.9, 0.6) 
MVPA -16.0 (-21.3, -10.7)  -12.8 (-17.9, -7.6)  -6.5 (-10.4, -2.5)  -22.4 (-27.7, -17.1)  -17.8 (-23.0, -12.5)  -6.9 (-10.9, -3.0) 
 
 
Model 1: adjusted for age. Model 2: adjusted for age, SEP, smoking history, long-term illness, health problem or disability, blood pressure and 
medication use. Model 3: as for model 2 plus added adjustment for fat mass index. 
 
 
PAEE -16.3 (-21.7, -10.9)  -12.7 (-18.0, -7.4)  -6.3 (-10.3, -2.2)  -25.7 (-31.1, -20.3)  -20.7 (-26.2, -15.2)  -6.8 (-11.0, -25.0) 
Adiponectin (♂=680; ♀=752)     
SED -6.7 (-11.7, -1.8)  -4.9 -10.1, 0.3)  -4.0 (-9.1, 1.1)  -11.4 (-15.6, -7.2)  -8.7 (-13.1, -4.3)  -5.2 (-9.6, -0.8) 
LPA 6.0 (1.0, 11.0)  4.4 (-0.7, 9.6)  4.0 (-1.0, 9.1)  -11.3 (7.0, 15.5)  8.9 (4.5, 13.2)  5.7 (1.4, 10.1) 
MVPA 5.0 (0.1, 9.8)  3. (-1.7, 8.2)  1.8 (-3.2, 6.7)  6.4 (2.3, 10.5)  3.6 (-0.6, 7.8)  0.6 (-3.6, 4.7) 
PAEE 6.8 (1.9, 11.7)  4.9 (-0.2, 9.9)  3.4 (-1.7, 8.4)  10.2 (6.0, 14.5)  7.3 (2.9, 11.6)  3.5 (-0.9, 7.9) 
